It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.
Study Type
OBSERVATIONAL
Enrollment
348
Caen University Hospital
Caen, France
Comparison between Jamar® and Gripwise® values for grip strength measurement
Intra-class correlation between the best values obtained with each device
Time frame: day1
comparison according to the patient's position
correlations of dynamometer measurements between patients assessed in the sitting or lying position
Time frame: day1
number of attempt to reach the maximum value
Comparison of the three measurements obtained for each patient with each device
Time frame: day1
factors influencing detected weakness
significant difference in the rate of women detected as weak with a handgrip \<16kg and men \<27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and ≥80 years
Time frame: day1
satisfaction using the devices
rate of patients finding one of both device easier to use
Time frame: day1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.